← Back to Search

Exercise for Chronic Kidney Disease

N/A
Recruiting
Research Sponsored by University of North Texas, Denton, TX
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Individuals with chronic kidney disease stages III-IV.
• Individuals with chronic kidney disease stages III-IV.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up cerebrovascular carbon dioxide reactivity will be compared at baseline (week 0) and after completing the 12-week intervention (week 13).
Awards & highlights

Study Summary

This trial will test if regular exercise may help improve how well the brain regulates blood flow in CKD patients.

Who is the study for?
This trial is for people with moderate to severe chronic kidney disease (stages III-IV). It's not suitable for those with heart failure, lung issues like COPD, uncontrolled blood pressure problems, pregnant women or those planning pregnancy, and individuals already exercising regularly.Check my eligibility
What is being tested?
The study is looking at how regular exercise might help the brain control blood flow in patients with chronic kidney disease. Participants will engage in supervised exercise routines including cycling and stretching exercises.See study design
What are the potential side effects?
While specific side effects are not listed for this trial, general risks may include muscle soreness, fatigue from the physical activity, and potential strain on the cardiovascular system due to exercise.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have moderate to severe kidney disease.
Select...
I have moderate to severe kidney disease.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~cerebrovascular carbon dioxide reactivity will be compared at baseline (week 0) and after completing the 12-week intervention (week 13).
This trial's timeline: 3 weeks for screening, Varies for treatment, and cerebrovascular carbon dioxide reactivity will be compared at baseline (week 0) and after completing the 12-week intervention (week 13). for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Carbon dioxide
Brain Concussion

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Exercise TrainingExperimental Treatment1 Intervention
Participants will exercise 3 times a week on a stationary bicycle. Exercise intensity will begin at low levels (50% of maximal heart rate reserve) and increase as tolerated to a maximum of 80% of maximal heart rate reserve. Exercise time will progress from an initial 20 minutes per session to a maximum of 45 minutes per session.
Group II: StretchingPlacebo Group1 Intervention
Participants will undergo progressive whole body stretching and balance exercises. This type of low intensity exercise is designed not to increase heart rate but rather to improve joint mobility and the ability to perform activities of daily living. This will serve as the control group to the exercise group. The control group will come in for stretching sessions 3 times per week for 20-45 minutes.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Exercise
2016
Completed Phase 1
~760

Find a Location

Who is running the clinical trial?

University of North Texas, Denton, TXLead Sponsor
9 Previous Clinical Trials
6,741 Total Patients Enrolled

Media Library

Exercise Clinical Trial Eligibility Overview. Trial Name: NCT05571605 — N/A
Chronic Kidney Disease Research Study Groups: Stretching, Exercise Training
Chronic Kidney Disease Clinical Trial 2023: Exercise Highlights & Side Effects. Trial Name: NCT05571605 — N/A
Exercise 2023 Treatment Timeline for Medical Study. Trial Name: NCT05571605 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Am I able to register for this clinical trial?

"This research trial has a limited capacity of 48, who must be between 30 and 75 years old and have advanced stages (III-IV) of chronic kidney disease."

Answered by AI

Do elderly individuals qualify to participate in this trial?

"The age range for inclusion in this trial has been specified as between 30 and 75 years old. Alternatively, there are other trials available to individuals below 18 years of age (43) and those above 65 (458)."

Answered by AI

Are there any opportunities to enroll in this trial presently?

"Affirmative. According to clinicaltrials.gov, this trial which was first advertised on August 1st 2022 is still open for recruitment. The most up-to-date information indicates that 48 patients are needed at a single location."

Answered by AI

What is the current enrollment quota for this research experiment?

"Affirmative. Clinicaltrials.gov records show that this trial was first advertised on August 1st, 2022 and is still actively recruiting candidates as of October 4th, 2022. The study seeks 48 volunteers from a single site."

Answered by AI

Who else is applying?

What state do they live in?
Texas
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Did not meet criteria
How many prior treatments have patients received?
0

Why did patients apply to this trial?

It's about kidneys and I'm very interested in how I can improve if possible my kidney function.
PatientReceived no prior treatments
Recent research and studies
clinicaltrials.govStudy
Cerebrovascular Dysregulation in Chronic Kidney Disease
Justin Sprick 2022. "Cerebrovascular Dysregulation in Chronic Kidney Disease". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05571605.
All > Chronic Kidney Disease
~15 spots leftby Mar 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top